The 23rd Awaji International Forum on Infection and Immunity

○Md. Golzar Hossain¹, Keiji Ueda² (1. Department of Microbiology and Hygiene, Bangladesh Agricultural University (Bangladesh), 2. Division of Virology, Department of Microbiology and Immunology, Graduate School of Medicine, Osaka University, Japan (Japan))

○sharmeen fayyaz¹, rishikesh lotke³, isabell Haussmann², Moritz Peterson², Daniel Sauter² (1. National Institute of Virology (Pakistan), 2. 1.Institute for Medical Virology and Epidemiology of Viral Diseases (Germany), 3. 3.Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig (Germany))

○Hina Miyazaki¹, Shungo Adachi², Kosuke Takada¹, Shintaro Shichinohe¹, Itsuki Anzai¹, Tokiko Watanabe^1,3,4 (1. Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. National Cancer Center Research Institute (Japan), 3. Center for Infectious Disease Education and Research (CiDER), The University of Osaka (Japan), 4. Center for Advanced Modalities and DDS (CAMaD), The University of Osaka (Japan))

○Maryam Sani Lawal^1,2,3, Kyoko Hayashida^1,2, Tatsuki Sugi ^1,2, Patrick Reteng ⁴, Junya Yamagishi^1,2,5 (1. Graduate School of Infectious Diseases, Hokkaido University, Sapporo, Japan. (Japan), 2. Division of Collaboration and Education International Institute for Zoonosis Control (Japan), 3. National Reference Laboratory, Nigeria Centre for Disease Control and Prevention, Abuja, Nigeria (Nigeria), 4. Department of Infection and Immunity, Luxembourg Institute of Health Luxembourg City, Luxembourg (Japan), 5. Global Station for Zoonosis Control, GI-CoRE, Hokkaido University, Sapporo, Hokkaido, Japan (Japan))

○Makoto Shimooka¹, Tomomi Kirino¹, Harumi Yamaguma², Natsumi Kameoka², Hina Miyazaki¹, Itsuki Anzai¹, Shintaro Shichinohe¹, Satoshi Obika^3,4,5,6, Yuuya Kasahara^2,5, Tokiko Watanabe^1,3,4 (1. Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. National Institutes of Biomedical Innovation, Health and Nutrition (Japan), 3. Center for Infectious Disease Education and Research, The University of Osaka (Japan), 4. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 5. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 6. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan))

○Qingxin Li¹, Shintaro Shichinohe¹, Hiroki Tanaka^2,3, Jessica Anindita³, Sara Yoshimoto¹, Kaewaroon Nantaporn^1,4, Makoto Shimooka¹, Itsuki Anzai¹, Hidetaka Akita^2,3, Tokiko Watanabe^1,2,5 (1. Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 3. Laboratory of DDS Design and Drug Disposition, Graduate School of Pharmaceutical Sciences, Tohoku University (Japan), 4. The National Vaccine Institute (Thailand), 5. Center for Infectious Disease Education and Research (CiDER), The University of Osaka (Japan))

○Merveille Kapandji¹, Htin Lin², Maurine Mumo Mutua¹, Qiang xu^1,3, Ryosaku Oshiro¹, Catarina Harumi Oda¹, Khine Mya Nwe¹, Shyam Prakash Dumre⁴, Kyaw Zin Thant⁵, War War Aung², Aye Aye Khin², Hlaing Myat Thu², Takeshi Urano⁶, Kouichi Morita^1,3,6,7, Yuki Takamatsu¹, Mya Myat Ngwe Tun^1,3,6,7 (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Medical Research, Ministry of Health (Myanmar), 3. DEJIMA Infectious Disease Research Alliance, Nagasaki University (Japan), 4. Central Department of Microbiology, Tribhuvan University (Nepal), 5. Myanmar Academy of Medical Science (Myanmar), 6. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 7. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan))

○MAN LIU¹, Da Teng¹, Tomoyuki Honda¹ (1. Okayama University (Japan))

○Thi Thanh Ngan Nguyen^1,3, Mya Myat Ngwe Tun^1,2,5,6, Thi Bich Hau Vu³, Thi Thu Thuy Nguyen³, Vu Mai Phuong Hoang³, Le Khanh Hang Nguyen³, Muhareva Raekiansyah¹, Jean Claude Balingit¹, Corazon C. Buerano¹, Yuki Takamatsu², Thi Quynh Mai Le³, Futoshi Hasebe⁴, Kouichi Morita^1,2,5,6 (1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. (Japan), 3. National Institute of Hygiene and Epidemiology, Hanoi, Vietnam. (Viet Nam), 4. Vietnam Research Station, Center for Infectious Disease Researcher in Asia and Africa, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. (Viet Nam), 5. DEJIMA Infectious Disease Research Alliance, Nagasaki University, Nagasaki, Japan (Japan), 6. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University, Izumo, Japan (Japan))

○Micheal Teron Pillay^1,2, Mai Thi Quynh Le³, Yuki Takamatsu¹, Phong Vu Tran³, Noboru Minakawa¹ (1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Department of Vaccine Informatics (Japan), 3. National Institute of Hygiene and Epidemiology (Viet Nam))

○Po-hung Wang¹, Kazuo Yamashita¹ (1. KOTAI Biotechnologies, Inc. (Japan))

○Kazuma Okada^1,2, Junki Hirano^1,2,3, Kentaro Uemura^1,2,3, Chikako Ono^1,2,3, Shuhei Taguwa^1,2,3, Yoshiharu Matsuura^1,2,3 (1. Laboratory of Virus Control, Center for Infectious Disease Education and Research, Osaka University (Japan), 2. Research Institute for Microbial Diseases (RIMD), Osaka University (Japan), 3. Center for Advanced Modalities and DDS (CAMaD), Osaka University (Japan))

○Hisano Yajima¹, Yuki Anraku², Yu Kaku³, Tomo Nomai², Kanako Terakado Kimura¹, Yoshiko Nakada-Nakura¹, Arnon Plianchaisuk³, Kaho Okumura^3,5, Yusuke Atarashi¹, Takuya Hemmi¹, Daisuke Kuroda⁶, Yoshimasa Takahashi⁴, Shunsuke Kita², Jiei Sasaki¹, Hiromi Sumita¹, Jumpei Ito³, Katsumi Maenaka², Kei Sato³, Takao Hashiguchi¹ (1. Kyoto University (Japan), 2. Hokkaido University (Japan), 3. The University of Tokyo (Japan), 4. Japan Institute for Health Security (Japan), 5. Sophia University (Japan), 6. Nihon University (Japan))

○Koji Yamauchi^1,2, Yukiko Muramoto^1,2, Yoko Fujita-Fujiharu^1,2,3, Ai Hirabayashi¹, Chiharu Nogami^1,3, Tsubasa Ishida^1,2, Yukihiko Sugita^1,2, Shinji Saito^4,5, Kaori Sano^4,6, Tadaki Suzuki^4,7, Masahiro Nakano^1,2,4, Takeshi Noda^1,2,8 (1. Laboratory of Ultrastructural Virology, Institue for Life and Medical Sciences, Kyoto University (Japan), 2. Laboratory of Ultrastructural Virology, Graduate School of Biostudies, Kyoto University (Japan), 3. Department of Cell and Virus Structure, Max Plank Institute of Biochemistry (Germany), 4. Department of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 5. Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University (Japan), 6. Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 7. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University (Japan), 8. Institute for Integrated Cell-Material Sciences, Kyoto University (Japan))